MAP2K7 and neoplasm: Recent research has found that Specnuezhenide can enhance the hematological and immunological functions of BMS mice, and it is speculated that it can significantly help the hematopoietic and immune functions of tumor patients after chemotherapy and plays a role by increasing the expression levels of key proteins MEK and p-ERK in the MAPK signaling pathway (Han et al., 2023).